Back to Authors

Smith, Charles D.

https://orcid.org/0000-0001-7185-5928

Mayo Clinic

Apogee Biotechnology (United States)

Citations 1

Antitumor effect of the novel sphingosine kinase 2 inhibitor ABC294640 is enhanced by inhibition of autophagy and by sorafenib in human cholangiocarcinoma cells
Ding, Xiwei , Chaiteerakij, Roongruedee , Moser, Catherine D., Shaleh, Hassan M., Boakye, Jeffrey, Ndzengue, Albert, Zhou, Yanling , Huang, Shengbing, Thomas, Melanie B., Smith, Charles D. , Roberts, Lewis R. , Shaleh, Hassan, Chen, Gang , Chaiteerakij, Roongruedee , Li, Ying , Sinicrope, Frank A. , Zou, Xiaoping , Roberts, Lewis R

Oncotarget | March 4, 2016 | Volume: 7 | Issue: 15 | Pages: 20080-20092

10.18632/oncotarget.7914 Get It